Start for free
Start for free
G

GKCC

North America, Delaware, United States, Wilmington

Description

GKCC operates as an investment firm.

Investor Profile

GKCC has made 6 investments, with 4 in the past 12 months and 50% as lead.

Stage Focus

  • Series A (33%)
  • Series Unknown (17%)
  • Post Ipo Equity (17%)
  • Post Ipo Debt (17%)
  • Seed (17%)

Country Focus

  • United States (83%)
  • Canada (17%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Medical Device
  • Pharmaceutical
  • Therapeutics
  • Health Diagnostics
  • Oncology
  • Electronic Health Record (Ehr)
  • Wellness
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does GKCC frequently co-invest with?

Boehringer Ingelheim Venture Fund
Boehringer Ingelheim Venture Fund
Europe, Rheinland-Pfalz, Germany, Ingelheim Am Rhein
Co-Investments: 1
5AM Ventures
5AM Ventures
North America, California, United States, Menlo Park
Co-Investments: 1
SC
Sheatree Capital
North America, New York, United States, Florida
Co-Investments: 1
HealthQuest Capital
HealthQuest Capital
North America, California, United States, Redwood City
Co-Investments: 1
Agilent Technologies
Agilent Technologies
North America, California, United States, Santa Clara
Co-Investments: 1
F-Prime Capital
F-Prime Capital
North America, Massachusetts, United States, Cambridge
Co-Investments: 1
Illumina Ventures
Illumina Ventures
North America, California, United States, Foster City
Co-Investments: 1
The Forest Road Company
The Forest Road Company
North America, New York, United States, New York
Co-Investments: 1
Arboretum Ventures
Arboretum Ventures
North America, Michigan, United States, Ann Arbor
Co-Investments: 1
JV
JLo Ventures
North America, Texas, United States, Plano
Co-Investments: 1

Which angels does GKCC often collaborate with?

RS
Ron Seubert
North America, Washington, United States, Seattle
Shared Deals: 1

What are some of recent deals done by GKCC?

Esphera SynBio

Ottawa, Ontario, Canada

Esphera SynBio operates as a biotechnology company.

BiotechnologyLife ScienceMedical
SeedJan 7, 2025
Amount Raised: $2,000,000
Tracer Biotechnologies

New York, New York, United States

Tracer Biotechnologies is a biotechnology company that offers monitoring services for oncology patients.

BiotechnologyElectronic Health Record (EHR)Health CareWellness
Series ADec 12, 2024
Amount Raised: $10,000,000
Elicio Therapeutics

Cambridge, Massachusetts, United States

Elicio Therapeutics is a pharmaceutical research company that develops an immuno-tumor vaccine to treat cancer.

BiotechnologyHealth CareMedicalPharmaceuticalTherapeutics
Post Ipo DebtAug 12, 2024
Amount Raised: $20,000,000
RareCyte

Seattle, Washington, United States

RareCyte is a life science research and diagnostic development company focused on characterizing and isolating rare cells in the blood.

BiotechnologyHealth CareHealth DiagnosticsMedical Device
Series UnknownJun 27, 2024
Amount Raised: $20,000,000
Elicio Therapeutics

Cambridge, Massachusetts, United States

Elicio Therapeutics is a pharmaceutical research company that develops an immuno-tumor vaccine to treat cancer.

BiotechnologyHealth CareMedicalPharmaceuticalTherapeutics
Post Ipo EquityDec 22, 2023
Amount Raised: $7,000,000
Actym Therapeutics, Inc.

Berkeley, California, United States

Actym Therapeutics is a biotech company that focuses on the discovery and development of novel immuno-oncology therapies to treat cancer.

BiotechnologyMedicalMedical DeviceOncology
Series AOct 18, 2023
Amount Raised: $25,500,000
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator